BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 30917943)

  • 1. MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer.
    Wang Y; Yu B; Zhong F; Guo Q; Li K; Hou Y; Lin N
    Magn Reson Imaging; 2019 Jul; 60():76-84. PubMed ID: 30917943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
    Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
    J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
    Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
    Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
    Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
    Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients.
    Zhang W; Mao N; Wang Y; Xie H; Duan S; Zhang X; Wang B
    Eur J Radiol; 2020 Jul; 128():109020. PubMed ID: 32371181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.
    Hectors SJ; Cherny M; Yadav KK; Beksaç AT; Thulasidass H; Lewis S; Davicioni E; Wang P; Tewari AK; Taouli B
    J Urol; 2019 Sep; 202(3):498-505. PubMed ID: 30958743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.
    Gondo T; Hricak H; Sala E; Zheng J; Moskowitz CS; Bernstein M; Eastham JA; Vargas HA
    Eur Radiol; 2014 Dec; 24(12):3161-70. PubMed ID: 25100337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
    Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
    J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric MRI-Based Radiomics for Prostate Cancer Screening With PSA in 4-10 ng/mL to Reduce Unnecessary Biopsies.
    Qi Y; Zhang S; Wei J; Zhang G; Lei J; Yan W; Xiao Y; Yan S; Xue H; Feng F; Sun H; Tian J; Jin Z
    J Magn Reson Imaging; 2020 Jun; 51(6):1890-1899. PubMed ID: 31808980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
    J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of prostate cancer aggressiveness with a combination of radiomics and machine learning-based analysis of dynamic contrast-enhanced MRI.
    Liu B; Cheng J; Guo DJ; He XJ; Luo YD; Zeng Y; Li CM
    Clin Radiol; 2019 Nov; 74(11):896.e1-896.e8. PubMed ID: 31495546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
    Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
    Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
    J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should bone scan be performed in Chinese prostate cancer patients at the time of diagnosis?
    Wang Y; Guo J; Xu L; Zhao N; Xu Z; Wang H; Zhu Y; Jiang S; Yang N; Yang Y; Wang G
    Urol Int; 2013; 91(2):160-4. PubMed ID: 23548369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI study.
    Sabouri S; Chang SD; Goldenberg SL; Savdie R; Jones EC; Black PC; Fazli L; Kozlowski P
    NMR Biomed; 2019 Feb; 32(2):e4048. PubMed ID: 30575145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction spectrum imaging improves MRI-based prostate cancer detection.
    McCammack KC; Schenker-Ahmed NM; White NS; Best SR; Marks RM; Heimbigner J; Kane CJ; Parsons JK; Kuperman JM; Bartsch H; Desikan RS; Rakow-Penner RA; Liss MA; Margolis DJ; Raman SS; Shabaik A; Dale AM; Karow DS
    Abdom Radiol (NY); 2016 May; 41(5):946-53. PubMed ID: 26910114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis.
    Vargas HA; Schor-Bardach R; Long N; Kirzner AN; Cunningham JD; Goldman DA; Moskowitz CS; Sosa RE; Sala E; Panicek DM; Hricak H
    Abdom Radiol (NY); 2017 Jan; 42(1):271-277. PubMed ID: 27480976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.